Lytenava’s EU approval contrasts sharply with repeated FDA rejections, as the agency continues to ask for additional confirmatory evidence. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
